Browsing Tag
biotech innovation
11 posts
How Apimeds’ ai² Futures Lab at the University of Idaho could redefine biotech innovation in the Northwest
Find out how Apimeds’ ai² Futures Lab partnership with the University of Idaho is shaping the next generation of biotech business development.
Clearmind Medicine files U.S. patent for non-hallucinogenic MEAI therapy targeting cocaine addiction
Find out how Clearmind Medicine’s new U.S. patent filing for its non-hallucinogenic MEAI therapy could transform cocaine addiction treatment and investor sentiment.
Can AI fix peptide drug development’s biggest bottlenecks—permeability and stability?
AI is transforming peptide drug design by tackling stability and permeability challenges. Find out how platforms like Atombeat are changing the rules.
Chai Discovery unveils Chai-2 AI breakthrough in fully de novo antibody design for next-gen drug discovery
Chai Discovery reveals Chai-2 AI breakthrough in antibody design with near 20% hit rate, outpacing traditional drug discovery methods. Learn how it transforms biotech.
Portal Biotechnologies awarded $8m DARPA contract to create portable red blood cell therapy system for rapid field-based treatment
Portal Biotechnologies secures $8M DARPA contract to build a field-deployable red blood cell therapy device using mechanoporation technology.
AbbVie to expand immunology pipeline with Nimble Therapeutics acquisition
In a significant move to solidify its presence in immunology, AbbVie has announced the acquisition of Nimble Therapeutics,…
Amplia Therapeutics secures FDA fast track status for narmafotinib in pancreatic cancer, stock surges
Amplia Therapeutics Limited (ASX: ATX) has announced that its Focal Adhesion Kinase (FAK) inhibitor, narmafotinib, has been granted…
Syngene International launches advanced protein production platform
Syngene International Ltd. (NSE: SYNGENE), a prominent global contract research, development, and manufacturing organization (CRDMO), has announced the…
WuXi Biologics and Toregem BioPharma to advance tooth regeneration treatment
WuXi Biologics (“WuXi Bio”), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced a strategic…
Evox Therapeutics secures £35.5m in Series B to advance exosome therapeutics
Evox Therapeutics, an innovative biotechnology company spun out from Oxford University, has successfully raised £35.5 million in a…